Misuse of Antibiotics Among the Population
DOI:
https://doi.org/10.31149/ijimm.v4i4.2859Keywords:
Antibiotics, Resistance, MRSA, MDR-TB, VRE, Rational Use, InfectionsAbstract
This article examines the problem of antibiotic resistance that develops in bacteria as a result of the improper use of antibiotics. It provides a detailed analysis of the main causes of misuse, the mechanisms of resistance development in bacteria, specific examples, and their impact on human health. Furthermore, particular attention is given to effective measures for reducing and preventing antibiotic resistance, including rational drug use, vaccination, hygiene, and the development of new treatment methods. The article aims to raise awareness among students, healthcare professionals, and the general public about the importance of the rational use of antibiotics.
References
C. L. Ventola, “The antibiotic resistance crisis: Part 1: Causes and threats,” P&T, vol. 40, no. 4, pp. 277–283, 2015.
C. L. Ventola, “The antibiotic resistance crisis: Part 2: Management strategies and new agents,” P&T, vol. 40, no. 5, pp. 344–352, 2015.
World Health Organization, “Antimicrobial resistance: Global solutions,” The Lancet Infectious Diseases, vol. 13, no. 12, pp. 1057–1098, 2020.
R. Laxminarayan et al., “Antibiotic resistance—the need for global solutions,” The Lancet Infectious Diseases, vol. 13, no. 12, pp. 1057–1098, 2013.
D. Davies and D. Davies, “Origins and evolution of antibiotic resistance,” Microbiology and Molecular Biology Reviews, vol. 74, no. 3, pp. 417–433, 2010.
Centers for Disease Control and Prevention, Antibiotic resistance threats in the United States. Atlanta, GA, USA, 2019.
A. H. Holmes et al., “Understanding the mechanisms and drivers of antimicrobial resistance,” The Lancet, vol. 387, no. 10014, pp. 176–187, 2016.
World Health Organization, Global action plan on antimicrobial resistance. Geneva, Switzerland, 2015.
E. Tacconelli et al., “Discovery, research, and development of new antibiotics,” The Lancet Infectious Diseases, vol. 18, no. 3, pp. 318–327, 2018.
J. O’Neill, Tackling drug-resistant infections globally: Final report and recommendations. London, UK, 2016.
Centers for Disease Control and Prevention, “Core elements of hospital antibiotic stewardship programs,” CDC, 2019.
F. Baquero and T. M. Coque, “Multilevel population genetics in antibiotic resistance,” FEMS Microbiology Reviews, vol. 35, no. 5, pp. 705–706, 2011.
K. Bush and P. A. Bradford, “β-lactams and β-lactamase inhibitors,” Cold Spring Harbor Perspectives in Medicine, vol. 6, no. 8, 2016.
L. B. Rice, “Antimicrobial resistance in Gram-positive bacteria,” The American Journal of Medicine, vol. 119, no. 6, pp. S11–S19, 2006.
World Health Organization, Antimicrobial resistance: Fact sheet. Geneva, Switzerland, 2021.
